Edwards Lifesciences to Present at the 2024 Wells Fargo Healthcare Conference
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/25/2026
- Wall St edges up on AI enthusiasm, Mideast negotiation hopes
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices drop about 3% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- Akamai signs $11.6B deal with Anthropic, up to $20B potential
- Bloom Energy falls as Oracle invokes force majeure on AI project
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oracle Sends Force Majeure Notice Over New Mexico Data Center - Bloomberg
- S&P 500 ends marginally lower as investors focus on US-Iran war
Citi Opens 90-Day Upside Catalyst Watch on Edwards Lifesciences (EW)
August 22, 2024 5:13 AM EDTCiti analyst Joanna Wuensch reiterated a Buy rating and $83.00 price target on Edwards Lifesciences (NYSE: EW).
The analyst comments "Heading into TCT, we are opening a 90-day Positive Catalyst Watch on Edwards. While we do not expect an outsized stock move... More
